How does ciprofloxacin compare to macrolides, such as azithromycin, in the management of respiratory tract infections and which is preferred for certain conditions?
Himanshu PrajapatiContributor
Sign Up to our social questions and Answers Engine to ask questions, answer people’s questions, and connect with other people.
Please briefly explain why you feel this question should be reported.
Please briefly explain why you feel this answer should be reported.
Please briefly explain why you feel this user should be reported.
Ciprofloxacin is powerful against Gram-negative bacteria and some Gram-positive, making it effective for acute exacerbations of chronic bronchitis. Azithromycin, a macrolide, is better suited for community-acquired pneumonia and chronic respiratory conditions due to its anti-inflammatory properties and good coverage against common respiratory pathogens. Overall, macrolides are often preferred due to a lower risk of serious side effects and broader effectiveness against typical respiratory infections.